Category: Publications

#StayInformed: Winter 25/26 PubMed picks

One Th2 Response, Two Outcomes: Itch Versus Inflammation?➜ DOI: 10.1111/exd.70171This research letter suggests that pruritus and inflammation may be driven by partially distinct Th2 programs. In mouse models of dermatitis, IL-31 is mainly produced by a specific subset of T cells, whereas IL-5 and IL-13 are largely derived from ILC2s. This cellular dissociation offers a plausible [...] Read More

#StayInformed: November 2025 PubMed picks

AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas

Read More

Abstract book from the 15th RAJKA-ISAD Melbourne 2025 @ActaDV

Suppl. Vol. 105 (2025). Immediate open access Please get your copy (authors retain copyright): 10.2340/actadv.v105.44874 About ActaDV Acta Dermato-Venereologica publishes high-quality manuscripts in the field of Dermatology and Venereology, dealing with new observations on basic dermatological and venereological research, as well as clinical investigations. Each volume features a number of Original articles in special areas, […]

Read More

#StayInformed: September 2025 PubMed picks

AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas

Read More

#StayInformed: August 2025 PubMed picks

AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas

Read More

#StayInformed: July 2025 PubMed picks

AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas

Read More

#StayInformed: June 2025 PubMed picks

AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas

Read More

#StayInformed: April 2025 PubMed picks

How COVID Quarantine May Have Fueled Infantile AD + Hidden Signs of Pruritus in Infants with AD + From Modeling Temperature Fluctuations to Blocking TRPV1: Restoring the Skin Barrier and Treating Pruritus + Can Early Short-Term Moisturizer Use Rewrite an Infant’s Microbiome and Prevent Atopic Dermatitis? + Serine Sensing System for tracking moisturizer treatment of a patient with AD

Read More

#StayInformed: March 2025 PubMed picks

Crusted Scabies and Dupilumab: A Case from Brazil + Seasonal Severity of AD by Birth Season: What’s the Culprit? + Primary Atopic Disorders (PADs): When Should This Be Considered? + Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) Lower the Risk of New-Onset Atopic Dermatitis in Diabetic Patients: Another Clue in the Salt Debate? + Targeting the OX40-OX40L Pathway: A New Era in AD Management?

Read More